At a glance
- Originator Nonindustrial source
- Class Antidementias; Small molecules
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Dementia
Most Recent Events
- 04 Apr 2001 Preclinical development for Dementia in Japan (Unknown route)